Last updated on August 2017

Severe Uncontrolled Asthma


Brief description of study

Severe Uncontrolled Asthma

Detailed Study Description

A multi-centered, randomized, double-blind, parelled, placebo-controlled, phase 3B study to evaluate the safety and efficacy of Benralizumab 30 mg sc in patients with severe ssthma uncontrolled on standard of care treatment.

Clinical Study Identifier: TX151880

Contact Investigators or Research Sites near you

Start Over

Cherish Semeski

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK USA
  Connect »